Expression mediated by three partial sequences of the human tyrosine hydroxylase promoter in vivo
Open Access
- 1 January 2016
- journal article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 3, 16062
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Closed-Loop and Activity-Guided Optogenetic ControlNeuron, 2015
- AAV Transduction of Dopamine Neurons With Constitutively Active Rheb Protects From Neurodegeneration and Mediates Axon RegrowthMolecular Therapy, 2012
- Dopaminergic pathway reconstruction by Akt/Rheb‐induced axon regenerationAnnals of Neurology, 2011
- A Neuroblastoma-Selective Suicide Gene Therapy Approach Using the Tyrosine Hydroxylase PromoterPediatric Research, 2004
- Cloning and cell type-specific regulation of the human tyrosine hydroxylase gene promoterBiochemical and Biophysical Research Communications, 2003
- Synergy between 5′ and 3′ flanking regions of the human tyrosine hydroxylase gene ensures specific, high-level expression in neuroblastoma cellsNeuroscience Letters, 2000
- High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system.Proceedings of the National Academy of Sciences, 1994
- Characterization of rat and human tyrosine hydroxylase genes: Functional expression of both promoters in neuronal and non-neuronal cell typesBiochemical and Biophysical Research Communications, 1988
- The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systemsJournal of Neuroscience, 1987
- The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systemsJournal of Neuroscience, 1987